Volume 21, Issue 2 (2018)                   mjms 2018, 21(2): 79-84 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Aghaie ‎ S, Mosavi ‎ S, Ebrahimi ‎ F, Salehi M, Nazarian S. Expression and Purification of Recombinant Catalytic Domain of ‎Botulinum Neurotoxin Type E from a Synthetic Gene. mjms. 2018; 21 (2) :79-84
URL: http://mjms.modares.ac.ir/article-30-1020-en.html
1- Biological Research Department, Basic Sciences Faculty, Imam Hossein University, Tehran, Iran‎
2- Biological Research Department, Basic Sciences Faculty, Imam Hossein University, Tehran, Iran , jmosavi@ihu.ac.ir
3- Biological Research Department, Basic Sciences Faculty, Imam Hossein University, Tehran, Iran
Abstract:   (7830 Views)
Aims: Botulinum neurotoxins are the strongest known bacterial toxins that cause muscle paralysis due to inhibition of acetylcholine release. Design of inhibitors is still pursued as a major strategy for intracellular inhibition of poisoning caused by these toxins. Investigation of the potential function of design inhibitors, pure poison or catalytic area is essential. The aims of present study were expression and purification of recombinant catalytic domain of botulinum neurotoxin type E (BoNT/E) Type E from a synthetic gene.
Materials and Methods: In this experimental study, the sequence of the botulinum neurotoxin type E light chain was adopted from GeneBank and codons were optimized according to E.coli BL21 (DE3) codon usage. Other bioinformatics tools were exploited to reach the optimum expression of the gene in the mentioned host. The resultant (gene) was then ordered to synthesize and cloning in pET28a (+) expression vector. The recombinant vector was transferred into E. coli BL21 (DE3) host cells. The expression of the protein was induced by addition of IPTG. The expression conditions were changed to obtain a soluble expression of the protein. Then, the protein was purified by an affinity chromatography, followed by a further purification with amicon filter. SDS-PAGE was used to evaluate expression and purification of the protein and Western blotting was performed to confirm the expressed protein.
Finding: Codon Adaptation Index of the gene increased to 0.85. The third predicted structure showed good quality. The thermodynamic analysis of the mRNA structure showed that the predicted structure is stable. The soluble expression was obtained in 18°C and 18h induction by 1 mM IPTG. Protein production with higher more than 90% purity was confirmed.
Conclusion: Optimization of the protein expression conditions resulted in producing the solution in the culture medium by E. coli BL21 as host.
Full-Text [PDF 414 kb]   (1281 Downloads)    
Article Type: Original Manuscipt | Subject: Biochemistry
Received: 2017/12/10 | Accepted: 2018/02/19

References
1. Thanongsaksrikul J, Chaicumpa W. Botulinum neurotoxins and botulism: a novel therapeutic approach. ‎Toxins (Basel). 2011;3(5):469-88.‎ [Link] [DOI:10.3390/toxins3050469]
2. Mousavi SJ, Rashidiani J, Farasat A, Ebrahimi F. Recombinant expression of light chain of botulinum ‎neurotoxin type-A in E. coli and evalution of its enzymatic activity. Mol Biol Res Commun. 2014;3(1):58-60. ‎‎[Persian]‎ [Link]
3. Leclair D, Farber JM, Pagotto F, Suppa S, Doidge B, Austin JW. Tracking sources of Clostridium botulinum ‎type E contamination in seal meat. Int J Circumpolar Health. 2017;76(1):1380994.‎ [Link] [DOI:10.1080/22423982.2017.1380994]
4. Kukreja R, Singh B. The botulinum toxin as a therapeutic agent: Molecular and pharmacological insights. ‎Res Rep Biochem. 2015;5:173-83.‎ [Link]
5. Lakshminarasimhan D, Kumaran D, Agarwal R, Singh BR. Cloning, expression and purification of ‎botulinum neurotoxin type A heavy chain-crystallographic evidence for a putative tetrameric pore. ‎Botulinum J. 2012;2(2):135-49. ‎ [Link] [DOI:10.1504/TBJ.2012.050196]
6. Horowitz BZ. Type E botulism. Clin Toxicol (Phila). 2010;48(9):880-95.‎ [Link] [DOI:10.3109/15563650.2010.526943]
7. Kiris E, Burnett JC, Kane CD, Bavari S. Recent advances in botulinum neurotoxin inhibitor development. ‎Curr Top Med Chem. 2014;14(18):2044-61.‎ [Link] [DOI:10.2174/1568026614666141022093350]
8. Mousavi ML, Kouhsari SM, Nazarian Sh, Rasooli I, Amani J. Cloning, expression and purification of ‎Clostridium botulinum neurotoxin type E binding domain. Iran J Biotechnol. 2004;2(3):183-8.‎ [Link]
9. Hamidi B, Ebrahimi F, Hajizadeh A, Hajizadeh A, Keshavarz Alikhani H. Fusion and cloning of the binding ‎domains of botulinum neurotoxin type A and B in E. coli DH5α. Eur J Experimental Biol. 2012;2(4):1154-60.‎ [Link]
10. Derman Y, Selby K, Miethe S, Frenzel A, Liu Y, Rasetti-Escargueil C, et al. Neutralization of botulinum ‎Neurotoxin Type E by a humanized antibody. Toxins (Basel). 2016;8(9):257.‎ [Link]
11. Agarwal R, Eswaramoorthy S, Kumaran D, Dunn JJ, Swaminathan S. Cloning, high level expression, ‎purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain. Protein ‎Expr Purif. 2004;34(1):95-102. ‎ [Link]
12. Agarwal R, Swaminathan S. SNAP-25 substrate peptide (residues 180–183) binds to but bypasses ‎cleavage by catalytically active Clostridium botulinum Neurotoxin E-. J Biol Chem. 2008;283(38):25944-51. ‎ [Link] [DOI:10.1074/jbc.M803756200]
13. Sambrook J, MacCallum P, Russell D. Molecular cloning A laboratory Manual. 3rd Volume. New York: Cold ‎Spring Harbor Laboratory Press; 2001. pp. 6-12.‎ [Link]
14. Ralph R. The nucleic acid protocols hand book. New York: Humana Press; 2000.‎ [Link]
15. Ebrahimi F, Rasaee MJ, Mousavi SL, Babaeipour V. Production and characterization of a recombinant ‎chimeric antigen consisting botulinum neurotoxin serotypes A, B and E binding subdomains. J Toxicol Sci. ‎‎2010;35(1):9-19.‎ [Link] [DOI:10.2131/jts.35.9]
16. Bollag DM, Rozycki MD, Edelstein SJ. Protein methods. New York: Wiley-Liss; 1991.‎ [Link]
17. Gouy M, Gautier C. Codon usage in bacteria: Correlation with gene expressivity. Nucleic Acids Res. ‎‎1982;10(22):7055-74.‎ [Link] [DOI:10.1093/nar/10.22.7055]
18. Zdanovsky AG, Zdanovskaia MV. Simple and efficient method for heterologous expression of clostridial ‎proteins. Appl Environ Microbiol. 2000;66(8):3166-73.‎ [Link] [DOI:10.1128/AEM.66.8.3166-3173.2000]
19. Lacy DB, Stevens RC. Sequence homology and structural analysis of the clostridial neurotoxins. J Mol Biol. ‎‎1999;291(5):1091-104.‎ [Link] [DOI:10.1006/jmbi.1999.2945]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.